AAAAAA

   
Results: 1-12 |
Results: 12
Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease
Authors: Mehta, PD Pirttila, T Patrick, BA Barshatzky, M Mehta, SP
Citation: Pd. Mehta et al., Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease, NEUROSCI L, 304(1-2), 2001, pp. 102-106
Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome
Authors: Schupf, N Patel, B Silverman, W Zigman, WB Zhong, N Tycko, B Mehta, PD Mayeux, R
Citation: N. Schupf et al., Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome, NEUROSCI L, 301(3), 2001, pp. 199-203
Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice
Authors: Sigurdsson, EM Scholtzova, H Mehta, PD Frangione, B Wisniewski, T
Citation: Em. Sigurdsson et al., Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice, AM J PATH, 159(2), 2001, pp. 439-447
Putting the individual back into individual growth curves
Authors: Mehta, PD West, SG
Citation: Pd. Mehta et Sg. West, Putting the individual back into individual growth curves, PSYCHOL MET, 5(1), 2000, pp. 23-43
Alpha(2) macroglobulin elevation without an acute phase response in depressed adults with Down's syndrome: implications
Authors: Tsiouris, JA Mehta, PD Patti, PJ Madrid, RE Raguthu, S Barshatzky, MR Cohen, IL Sersen, E
Citation: Ja. Tsiouris et al., Alpha(2) macroglobulin elevation without an acute phase response in depressed adults with Down's syndrome: implications, J INTEL DIS, 44, 2000, pp. 644-653
Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease
Authors: Tapiola, T Pirttila, T Mikkonen, M Mehta, PD Alafuzoff, I Koivisto, K Soininen, H
Citation: T. Tapiola et al., Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease, NEUROSCI L, 280(2), 2000, pp. 119-122
Relationship between apoE genotype and CSF beta-amyloid (1-42) and tan in patients with probable and definite Alzheimer's disease
Authors: Tapiola, T Pirttila, T Mehta, PD Alafuzoff, I Lehtovirta, M Soininen, H
Citation: T. Tapiola et al., Relationship between apoE genotype and CSF beta-amyloid (1-42) and tan in patients with probable and definite Alzheimer's disease, NEUROBIOL A, 21(5), 2000, pp. 735-740
Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease
Authors: Mehta, PD Pirttila, T Mehta, SP Sersen, EA Aisen, PS Wisniewski, HM
Citation: Pd. Mehta et al., Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease, ARCH NEUROL, 57(1), 2000, pp. 100-105
Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster
Authors: Pirttila, T Haanpaa, M Mehta, PD Lehtimaki, T
Citation: T. Pirttila et al., Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster, ACT NEUR SC, 102(2), 2000, pp. 94-98
Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease
Authors: Mayeux, R Tang, MX Jacobs, DM Manly, J Bell, K Merchant, C Small, SA Stern, Y Wisniewski, HM Mehta, PD
Citation: R. Mayeux et al., Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease, ANN NEUROL, 46(3), 1999, pp. 412-416
Increased levels of tau-like protein in patients with Down syndrome
Authors: Mehta, PD Patrick, BA Dalton, AJ Aisen, PS Emmerling, ME Sersen, EA Wisniewski, HM
Citation: Pd. Mehta et al., Increased levels of tau-like protein in patients with Down syndrome, NEUROSCI L, 275(3), 1999, pp. 159-162
Improved discrimination of AD patients using beta-amyloid((1-42)) and tau levels in CSF
Authors: Hulstaert, F Blennow, K Ivanoiu, A Schoonderwaldt, HC Riemenschneider, M De Deyn, PP Bancher, C Cras, P Wiltfang, J Mehta, PD Iqbal, K Pottel, H Vanmechelen, E Vanderstichele, H
Citation: F. Hulstaert et al., Improved discrimination of AD patients using beta-amyloid((1-42)) and tau levels in CSF, NEUROLOGY, 52(8), 1999, pp. 1555-1562
Risultati: 1-12 |